MaxCyte, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
MaxCyte, Inc. (MXCT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 13.57 million shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-03-25
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.57M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 14.06M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 15.42M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 14.36M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2025-12-31 | 13.57M shares 10-K · filed 2026-03-25 |
| 2024-12-31 | 14.06M shares 10-K · filed 2026-03-25 |
| 2023-12-31 | 15.42M shares 10-K · filed 2026-03-25 |
| 2022-12-31 | 14.36M shares 10-K · filed 2025-03-11 |
| 2021-12-31 | 12.43M shares 10-K · filed 2024-03-12 |
| 2020-12-31 | 12.86M shares 10-K · filed 2023-03-15 |
| 2019-12-31 | 10.30M shares 10-K · filed 2022-03-22 |
| 2018-12-31 | 8.39M shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |